VANCOUVER, CANADA – November 3, 2020, Evasc today announced that the new Electrolytic eCLIPs Bifurcation Remodeling System (eB) has been granted CE Mark approval. The eB builds upon eCLIPs highly effective design, incorporating an improved delivery system with a torquable wire, a smaller size that is compatible with 021 and 027 microcatheters, and electrolytic detachment.
“We have listened to the experts in the neuro field and developed an improved version that is smaller and easier to use. This will allow treatment for a wider range of aneurysms and shorten delivery times,” said Dr. Donald Ricci, President and Chief Executive Officer of Evasc. “The previous version showed exceptional outcome due to the eCLIPs implant's ability to bridge the neck of the aneurysm and to create a flow diversion effect. This new and improved version retains these favourable characteristics and also allows eCLIPs to gain access to smaller and more distant vessels within the cerebral anatomy.”
eCLIPs is a non-tubular endovascular device currently targeted for use in challenging wide-neck bifurcations, but whose technology is designed to treat 95% of cerebral aneurysm cases. eCLIPs’ unique design provides not only coil retention, but also flow diversion at the neck. eCLIPs avoids dangerous entry into the dynamic, fragile environment of the aneurysm sac while leaving side branches unencumbered and providing a platform for endothelial growth across the bifurcation neck.
Evasc is a privately-held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms. Evasc is headquartered in Vancouver, Canada.
Evasc is on the web at www.evasc.com.
For more information, contact Scott Wilson at +1 (604) 742-3811, email@example.com.